✨ Medicines Act Notices




28 OCTOBER NEW ZEALAND GAZETTE 3837

Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Visipaque.
Active Ingredient(s): Iodixanol 305 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Nycomed New Zealand Limited.
Manufacturer(s): Nycomed AS Production, Oslo, Norway.
Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire.

Product: Visipaque.
Active Ingredient(s): Iodixanol 550 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Nycomed New Zealand Limited.
Manufacturer(s): Nycomed AS Production, Oslo, Norway.
Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire.
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico.

Product: Visipaque.
Active Ingredient(s): Iodixanol 652 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Nycomed New Zealand Limited.
Manufacturer(s): Nycomed AS Production, Oslo, Norway.
Nycomed Ireland Limited, Carrigtohil, Co. Cork, Eire.
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico.

Dated this 22nd day of October 1999.

S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

g07001

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Ametop.
Active Ingredient(s): Amethocaine hydrochloride 4.551% w/w equivalent to 4.0% w/w amethocaine base.
Dosage Form: Topical gel.
NZ Sponsor: Smith & Nephew Limited.
Manufacturer(s): CP Pharmaceuticals Limited, Wrexham, Wales.

Product: Celol.
Active Ingredient(s): Celiprolol hydrochloride 200 mg.
Dosage Form: Film coated tablet.
NZ Sponsor: Pacific Pharmaceuticals Limited.
Manufacturer(s): Pacific Pharmaceuticals Limited, Mount Wellington, Auckland.

Product: Johnson's Baby Nappy Rash Treatment Cream.
Active Ingredient(s): Zinc oxide 130 mg/g.
Dosage Form: Topical cream.
NZ Sponsor: Johnson & Johnson Pacific Pty Limited.
Manufacturer(s): Milpharma Pty Limited, Brookvale, New South Wales, Australia.

Dated this 22nd day of October 1999.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 161


NZLII PDF NZ Gazette 1999, No 161





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
22 October 1999
Medicines, Distribution, Consent, Visipaque, Iodixanol
  • S. S. Jessamine, Acting Chief Advisor, Safety and Regulation

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
22 October 1999
Medicines, Distribution, Consent, Ametop, Celol, Johnson's Baby Nappy Rash Treatment Cream
  • S. S. Jessamine, Acting Chief Advisor, Safety and Regulation